Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia

Biochem Biophys Res Commun. 1984 Feb 29;119(1):58-63. doi: 10.1016/0006-291x(84)91617-6.

Abstract

Hypoxia provokes pulmonary constriction and because PAF-acether is a very strong pulmonary constrictor, we looked for PAF-acether in lung alveolar lavage (LAL) with a biological method based on the measurement of rabbit platelet aggregation. We first demonstrated a PAF-acether secretion during bronchoalveolar lavage with sterile isotonic NaCl (pH 7.2). PAF-acether secretion was completely suppressed with isotonic NaCl containing 5 mM EDTA but lyso-PAF-acether was still present (1.9 +/- 0.55 nmoles). Upon hypobaric hypoxia, PAF-acether was detected in LAL (1.05 +/- 0.25 10(-2)nmoles). The amount of lyso-PAF-acether increased by 6 times (12.1 +/- 4.1 nmoles). These results are given for 10(4) nmoles phospholipids of LAL. They indicate that alveolar macrophages might be activated by hypobaric hypoxia, so they produce PAF-acether in the alveole. Such a process could be involved in the well-known bronchoconstriction accompanying hypoxia.

MeSH terms

  • Animals
  • Biological Assay
  • Bronchi / physiology
  • Edetic Acid / pharmacology
  • Hypoxia / metabolism*
  • Male
  • Platelet Activating Factor / analogs & derivatives
  • Platelet Activating Factor / physiology*
  • Platelet Aggregation
  • Pulmonary Alveoli / metabolism*
  • Rabbits
  • Rats
  • Rats, Inbred Strains

Substances

  • O-deacetyl platelet activating factor
  • Platelet Activating Factor
  • Edetic Acid